维普中文期刊产品整合服务
121篇 您的检索式:作者名="AVVISATI G"
    题名 作者 年代 出处 被引量
1Pamidronate induces modifications of circulating angiogenetic factors in cancer patients显示文摘D·Santini B·Vincenzi G·Avvisati 2002Clinical Cancer Research2002,8,5:1
2Early dete ction of relapse by prospective reverse transcriptase-polymerase chain reactin analysis of the PMIL/RAR alpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter'AIDA'trial GIMEMA-AIEOP Muhicenter 'AIDA'trial显示文摘Diverio D Rossi V Avvisati G 1998Blood1998,92,:1
3Coagulopathy in APL: a step forward显示文摘Avvisati G 2012Blood2012,120,1:1
4显示文摘 Spadea A Avvisati G 1998Leukemia1998,12,6:1
5Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia:final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up显示文摘Avvisati G Petti M C Lo-Coco F 2002Blood2002,100,9:1
6ATRA and arsenic trioxide (ATO) versus ATRA and idarubicin (AI- DA) for newly diagnosed, non high-risk acute promyelo- cytie leukemia (APL) : results of the phase III, prospec- tive, randomized, intergroup APL0406 study by the Ital- ian-German cooperative groups GIMEMA-SAL-AMLSG 显示文摘Lo Coco F Avvisati G Orlando S M 2012Blood2012,120,1:1
7Acute promylocytic leukemia: a curable disease显示文摘LOCOCO F NERVI C AVVISATI G 2003Leukemia2003,12,5:1
8Retinoic acid and arsenic trioxide for acute promyelocytic leukemia 显示文摘Lo-CocoF Avvisati G Vignetti M 2013N Engl J Med2013,369,2:1
9Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of- life outcomes显示文摘Efficace F MandeUi F Avvisati G 2014J Clin Oncol2014,32,30:1
10Pamidronate inducesmodifications of circulating angiogenetic factors in cancer patients显示文摘Santini D Vineenzi B Avvisati G 2002Clin Cancer Res2002,8,5:1
11AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia:very longterm results and role of maintenance显示文摘Avvisati G Lo-Coco F Paoloni FP 2011Blood2011,117,18:1
12Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 显示文摘Lo-Coco F Avvisati G Vignetti M 2010Blood2010,116,17:1
13Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation : results of the AIDA-2000 trial of the Italian GIMEMA Group显示文摘Lo Coco F Avvisati G Vignetti M 2004Blood2004,104,11:1
14Pathogenetic,Clinical,and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia显示文摘Marchesi F Girardi K Avvisati G 0,,15:1
15Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for aduhsyounger than 61 years: results of the AIDA-2000 trial of the group显示文摘Lo-Coco F Avvisati G Vignetti M 2010Blood2010,116,17:1
16Early haemorrhagic morbid- ity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia显示文摘Di Bona E Avvisati G Castaman G 2000Br J Haematol2000,108,4:1
17Thrombocytopenia and hemorrhagic risk in cancer patients显示文摘Avvisati G Tirindelli MC Annibali O 2003Cirit Rev Oncol Hematol2003,,:1
18Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘Lo-Coco F Avvisati G Vignetti M 2013New Engl J Med2013,369,2:1
19AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance显示文摘Avvisati G Lo-Coco F Paoloni FP 2011Blood2011,117,18:1
20Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘Lo-Coco F Avvisati G Vignetti M 2013N Engl J Med2013,369,2:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费